PURPOSE: Chronic graft-versus-host disease (cGVHD) is a significant cause of mortality and morbidity after allogeneic hematopoietic cell transplant and is associated with a wide range of distressing symptoms. A pediatric measure of cGVHD-related symptoms is needed to advance clinical research. Our aim was to elicit descriptions of the cGVHD symptom experience directly from children and to compare the specific language used by children to describe their symptoms and the comprehension of symptom concepts across the developmental spectrum. METHODS: We used qualitative methods to identify the phrases, terms, and constructs that children (ages 5–8 [n =8], 9–12 [n =8], and 13–17 [n =8]) with cGVHD employ when describing their symptoms. The symptom experience of each participant was determined through individual interviews with each participant and parent (5–7 year olds were interviewed together with a parent). Medical practitioners with experience in evaluating cGVHD performed clinical assessments of each participant. RESULTS: Pediatric transplant survivors and their parents identified a wide range of bothersome cGVHD symptoms, and common concepts and terminologies to describe these experiences emerged. Overall concordance between patient and parent reports was moderate (70–75 %). No consistent pattern of child under- or over-reporting in comparison to the parent report was observed. CONCLUSION: These study results identify concepts and vocabulary to inform item generation for a new pediatric self-report measure of cGVHD symptoms for use in clinical research. The findings also confirm the prevalence and nature of symptom distress in pediatric patients with cGVHD and support implementation of systematic approaches to symptom assessment and intervention in routine clinical practice.
PURPOSE: Chronic graft-versus-host disease (cGVHD) is a significant cause of mortality and morbidity after allogeneic hematopoietic cell transplant and is associated with a wide range of distressing symptoms. A pediatric measure of cGVHD-related symptoms is needed to advance clinical research. Our aim was to elicit descriptions of the cGVHD symptom experience directly from children and to compare the specific language used by children to describe their symptoms and the comprehension of symptom concepts across the developmental spectrum. METHODS: We used qualitative methods to identify the phrases, terms, and constructs that children (ages 5–8 [n =8], 9–12 [n =8], and 13–17 [n =8]) with cGVHD employ when describing their symptoms. The symptom experience of each participant was determined through individual interviews with each participant and parent (5–7 year olds were interviewed together with a parent). Medical practitioners with experience in evaluating cGVHD performed clinical assessments of each participant. RESULTS: Pediatric transplant survivors and their parents identified a wide range of bothersome cGVHD symptoms, and common concepts and terminologies to describe these experiences emerged. Overall concordance between patient and parent reports was moderate (70–75 %). No consistent pattern of child under- or over-reporting in comparison to the parent report was observed. CONCLUSION: These study results identify concepts and vocabulary to inform item generation for a new pediatric self-report measure of cGVHD symptoms for use in clinical research. The findings also confirm the prevalence and nature of symptom distress in pediatric patients with cGVHD and support implementation of systematic approaches to symptom assessment and intervention in routine clinical practice.
Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring Journal: Value Health Date: 2011-10-13 Impact factor: 5.725
Authors: David A Jacobsohn; Brenda F Kurland; Joseph Pidala; Yoshihiro Inamoto; Xiaoyu Chai; Jeanne M Palmer; Sally Arai; Mukta Arora; Madan Jagasia; Corey Cutler; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Georgia Vogelsang; Stephanie J Lee; Mary E D Flowers Journal: Blood Date: 2012-07-06 Impact factor: 22.113
Authors: Susan K Parsons; Mei-Chiung Shih; Katherine N Duhamel; Jamie Ostroff; Deborah K Mayer; Jane Austin; D Richard Martini; Sharon E Williams; Laura Mee; Sandra Sexson; Sherrie H Kaplan; William H Redd; Sharon Manne Journal: J Pediatr Psychol Date: 2005-09-08
Authors: Steven Z Pavletic; Paul Martin; Stephanie J Lee; Sandra Mitchell; David Jacobsohn; Edward W Cowen; Maria L Turner; Gorgun Akpek; Andrew Gilman; George McDonald; Mark Schubert; Ann Berger; Peter Bross; Jason W Chien; Daniel Couriel; J P Dunn; Jane Fall-Dickson; Ann Farrell; Mary E D Flowers; Hildegard Greinix; Steven Hirschfeld; Lynn Gerber; Stella Kim; Robert Knobler; Peter A Lachenbruch; Frederick W Miller; Barbara Mittleman; Esperanza Papadopoulos; Susan K Parsons; Donna Przepiorka; Michael Robinson; Michael Ward; Bryce Reeve; Lisa G Rider; Howard Shulman; Kirk R Schultz; Daniel Weisdorf; Georgia B Vogelsang Journal: Biol Blood Marrow Transplant Date: 2006-03 Impact factor: 5.742
Authors: Yoshihiro Inamoto; Paul J Martin; Xiaoyu Chai; Madan Jagasia; Jeanne Palmer; Joseph Pidala; Corey Cutler; Steven Z Pavletic; Mukta Arora; David Jacobsohn; Paul A Carpenter; Mary E D Flowers; Nandita Khera; Georgia B Vogelsang; Daniel Weisdorf; Barry E Storer; Stephanie J Lee Journal: Biol Blood Marrow Transplant Date: 2012-06-06 Impact factor: 5.742
Authors: Smita Bhatia; Meriel E M Jenney; Eric Wu; Monica K Bogue; Todd H Rockwood; James H Feusner; Debra L Friedman; Leslie L Robison; Robert L Kane Journal: J Pediatr Date: 2004-07 Impact factor: 4.406
Authors: H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas Journal: Am J Med Date: 1980-08 Impact factor: 4.965
Authors: James W Varni; Sandra A Sherman; Tasha M Burwinkle; Paige E Dickinson; Pamela Dixon Journal: Health Qual Life Outcomes Date: 2004-09-27 Impact factor: 3.186
Authors: L M Curtis; L Grkovic; S A Mitchell; S M Steinberg; E W Cowen; M B Datiles; J Mays; C Bassim; G Joe; L E Comis; A Berger; D Avila; T Taylor; D Pulanic; K Cole; J Baruffaldi; D H Fowler; R E Gress; S Z Pavletic Journal: Bone Marrow Transplant Date: 2014-08-25 Impact factor: 5.483
Authors: Stephanie J Lee; Daniel Wolff; Carrie Kitko; John Koreth; Yoshihiro Inamoto; Madan Jagasia; Joseph Pidala; Attilio Olivieri; Paul J Martin; Donna Przepiorka; Iskra Pusic; Fiona Dignan; Sandra A Mitchell; Anita Lawitschka; David Jacobsohn; Anne M Hall; Mary E D Flowers; Kirk R Schultz; Georgia Vogelsang; Steven Pavletic Journal: Biol Blood Marrow Transplant Date: 2015-03-19 Impact factor: 5.742
Authors: A Lawitschka; E D Güclü; J W Varni; M Putz; D Wolff; S Pavletic; H Greinix; C Peters; R Felder-Puig Journal: Bone Marrow Transplant Date: 2014-05-12 Impact factor: 5.483
Authors: Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic Journal: Bone Marrow Transplant Date: 2018-06-05 Impact factor: 5.483